Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma
- PMID: 29868315
- PMCID: PMC5978855
- DOI: 10.1055/s-0037-1604363
Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma
Abstract
Objectives Pituitary adenoma (PA), among the most commonly encountered sellar pathologies, accounts for 10% of primary intracranial tumors. The reported incidence of postoperative diabetes insipidus (DI) is highly variable. In this study, we report our experience with DI following endoscopic transsphenoidal surgery (TSS) for PAs, elucidating the risk factors of postoperative DI, the likelihood of long-term DI, and the impact of DI on the length of stay (LOS). Methods The study included 178 patients who underwent endoscopic resection of PAs. Early DI was defined as that occurring within the first postoperative week. The mean follow-up was 36 months. Long-term DI was considered as DI apparent in the last follow-up visit. Results Of the 178 patients included in the study, 77% of the tumors were macroadenomas. Forty-seven patients (26%) developed early DI. Long-term DI was observed in 18 (10.1%) of the full cohort. Age younger than 50 years was significantly associated with a higher incidence of long-term DI ( p = 0.02). Macroadenoma and gross total resection were significantly associated with higher incidence of early DI ( p = 0.05 and p = 0.04, respectively). The mean LOS was 4 days for patients with early postoperative DI and 3 days for those without it. Conclusion The reported incidence of postoperative DI is significantly variable. We identified age younger than 50 years a risk factor for developing long-term postoperative DI. Gross total surgical resection and tumor size (> 1 cm) were associated with development of early DI. Early DI increased the LOS on average by 1 day.
Keywords: diabetes insipidus; endoscopic transsphenoidal; pituitary adenoma; postoperative hypernatremia.
Conflict of interest statement
Figures
Similar articles
-
Is it possible to predict the development of diabetes insipidus after pituitary surgery? Study of 241 endoscopic transsphenoidal pituitary surgeries.J Endocrinol Invest. 2021 Jul;44(7):1457-1464. doi: 10.1007/s40618-020-01448-6. Epub 2020 Oct 11. J Endocrinol Invest. 2021. PMID: 33043415
-
Incidence of Diabetes Insipidus in Postoperative Period among the Patients Undergoing Pituitary Tumour Surgery.Mymensingh Med J. 2017 Jul;26(3):642-649. Mymensingh Med J. 2017. PMID: 28919622
-
Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors.Neurosurg Rev. 2021 Jun;44(3):1503-1511. doi: 10.1007/s10143-020-01340-0. Epub 2020 Jun 24. Neurosurg Rev. 2021. PMID: 32583307
-
Importance of Intraoperative Factors in Postoperative Arginine Vasopressin Deficiency After Pituitary Adenoma Surgery.Endocr Pract. 2024 Mar;30(3):253-258. doi: 10.1016/j.eprac.2023.12.003. Epub 2023 Dec 11. Endocr Pract. 2024. PMID: 38092289 Review.
-
Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.J Neurosurg. 2015 Jul;123(1):31-8. doi: 10.3171/2014.10.JNS14372. Epub 2015 Apr 3. J Neurosurg. 2015. PMID: 25839926 Review.
Cited by
-
Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure.Endocrine. 2022 Nov;78(2):354-362. doi: 10.1007/s12020-022-03164-y. Epub 2022 Aug 19. Endocrine. 2022. PMID: 35984619 Free PMC article.
-
Is it possible to predict the development of diabetes insipidus after pituitary surgery? Study of 241 endoscopic transsphenoidal pituitary surgeries.J Endocrinol Invest. 2021 Jul;44(7):1457-1464. doi: 10.1007/s40618-020-01448-6. Epub 2020 Oct 11. J Endocrinol Invest. 2021. PMID: 33043415
-
Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.J Neurooncol. 2021 Jun;153(2):343-350. doi: 10.1007/s11060-021-03774-y. Epub 2021 May 17. J Neurooncol. 2021. PMID: 34002303
-
Postoperative water and electrolyte disturbances after extended endoscopic endonasal transsphenoidal surgery.Front Endocrinol (Lausanne). 2022 Aug 23;13:963707. doi: 10.3389/fendo.2022.963707. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36082073 Free PMC article.
-
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma.Pituitary. 2022 Feb;25(1):100-107. doi: 10.1007/s11102-021-01175-y. Epub 2021 Jul 20. Pituitary. 2022. PMID: 34283369
References
-
- Pinar E, Yuceer N, Imre A, Guvenc G, Gundogan O. Endoscopic endonasal transsphenoidal surgery for pituitary adenomas. J Craniofac Surg. 2015;26(01):201–205. - PubMed
-
- Gondim J A, Almeida J P, Albuquerque L A et al.Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary. 2011;14(02):174–183. - PubMed
-
- Jho H-D, Carrau R L. Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note. Acta Neurochir (Wien) 1996;138(12):1416–1425. - PubMed
-
- Chabot J D, Chakraborty S, Imbarrato G, Dehdashti A R. Evaluation of outcomes after endoscopic endonasal surgery for large and giant pituitary macroadenoma: a retrospective review of 39 consecutive patients. World Neurosurg. 2015;84(04):978–988. - PubMed
-
- Berker M, Hazer D B, Yücel T et al.Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary. 2012;15(03):288–300. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources